New Advances in Clinical Diagnosis and Management of Gastroparesis

doi:10.12114/j.issn.1007-9572.2021.00.437

Abstract

Abstract: Gastroparesis is a rare gastrointestinal motility disorder，which can be caused by many reasons，but the causative mechanism is still unclear.Gastroparesis has two main subtypes，idiopathic gastroparesis（primary）and diabetic gastroparesis（secondary），and an essential symptom of delayed gastric emptying.Diet modification and prokinetic drugs are initial treatments for gastroparesis，but how to significantly improve it is still a difficult problem.The recently emerged technologies have shed light on its diagnosis and treatment.This paper mainly summarized and analyzed new advances in clinical diagnosis and management of gastroparesis，aiming to provide a reference for clinical diagnosis and management of this disease.

Key words: Gastroparesis, Diagnosis, Therapy, Prokinetic drug, Botulinum neurotoxin, Gastroelectric stimulation, Gastric peroral endoscopic myotomy

摘要： 胃轻瘫是临床上较为少见的胃肠动力障碍疾病之一，其病因多样，发病机制尚不明确，以特发性胃轻瘫（原发性）和糖尿病胃轻瘫（继发性）多见。胃排空延迟是诊断胃轻瘫的必要条件，而改善胃轻瘫是现阶段临床难点之一。饮食调整和促动力药物是目前治疗胃轻瘫的基础，近年来新兴诊疗技术的发展为胃轻瘫的诊断和治疗提供了新思路。本文主要总结、分析了近年来胃轻瘫临床诊断和治疗方面的新进展，以期为提高临床胃轻瘫诊疗水平提供参考。

关键词: 胃肌轻瘫, 诊断, 治疗, 促动力药, 肉毒素, 胃电刺激, 经口内镜下胃幽门肌切开术

JIANG Ya,LIN Lin. New Advances in Clinical Diagnosis and Management of Gastroparesis　[J]. Chinese General Practice, 2021, 24(15): 1978-1983. DOI: 10.12114/j.issn.1007-9572.2021.00.437.
姜亚,林琳. 胃轻瘫临床诊断和治疗的新进展[J]. 中国全科医学, 2021, 24(15): 1978-1983. DOI: 10.12114/j.issn.1007-9572.2021.00.437.

References

［1］JUNG H K，CHOUNG R S，LOCKE G R 3rd，et al．The incidence，prevalence，and outcomes of patients with gastroparesis in Olmsted County，Minnesota，from 1996 to 2006［J］．Gastroenterology，2009，136（4）：1225-1233．DOI：10.1053/j.gastro.2008.12.047.
［2］REY E，CHOUNG R S，SCHLECK C D，et al．Prevalence of hidden gastroparesis in the community：the gastroparesis “iceberg”［J］．J Neurogastroenterol Motil，2012，18（1）：34-42．DOI：10.5056/jnm.2012.18.1.34.
［3］WOODHOUSE S，HEBBARD G，KNOWLES S R.Psychological controversies in gastroparesis：a systematic review［J］．World J Gastroenterol，2017，23（7）：1298-1309．DOI：10.3748/wjg.v23.i7.1298.
［4］CAMILLERI M，PARKMAN H P，SHAFI M A，et al．Clinical guideline：management of gastroparesis［J］．Am J Gastroenterol，2013，108（1）：18-37；quiz 38．DOI：10.1038/ajg.2012.373.
［5］LACY B E，PARKMAN H P，CAMILLERI M.Chronic nausea and vomiting：evaluation and treatment［J］．Am J Gastroenterol，2018，113（5）：647-659．DOI：10.1038/s41395-018-0039-2.
［6］SOYKAN I，SIVRI B，SAROSIEK I，et al．Demography，clinical characteristics，psychological and abuse profiles，treatment，and long-term follow-up of patients with gastroparesis［J］．Dig Dis Sci，1998，43（11）：2398-2404．DOI：10.1023/a：1026665728213.
［7］CHOUNG R S，LOCKE G R 3rd，SCHLECK C D，et al．Risk of gastroparesis in subjects with type 1 and 2 diabetes in the general population［J］．Am J Gastroenterol，2012，107（1）：82-88．DOI：10.1038/ajg.2011.310.
［8］CAMILLERI M，BHARUCHA A E，FARRUGIA G.Epidemiology，mechanisms，and management of diabetic gastroparesis［J］．Clin Gastroenterol Hepatol，2011，9（1）：5-12；quiz e7．DOI：10.1016/j.cgh.2010.09.022.
［9］CAMILLERI M，ITURRINO J，BHARUCHA A E，et al．Performance characteristics of scintigraphic measurement of gastric emptying of solids in healthy participants［J］．Neurogastroenterol Motil，2012，24（12）：1076-e562．DOI：10.1111/j.1365-2982.2012.01972.x.
［10］CAMILLERI M，ZINSMEISTER A R，GREYDANUS M P，et al．Towards a less costly but accurate test of gastric emptying and small bowel transit［J］．Dig Dis Sci，1991，36（5）：609-615．DOI：10.1007/BF01297027.
［11］ABELL T L，CAMILLERI M，DONOHOE K，et al．Consensus recommendations for gastric emptying scintigraphy：a joint report of the American Neurogastroenterology and Motility Society and the Society of Nuclear Medicine［J］．J Nucl Med Technol，2008，31（1）：44-54．DOI：10.2967/jnmt.107.048116.
［12］CHEN J D，LIN Z，PAN J，et al．Abnormal gastric myoelectrical activity and delayed gastric emptying in patients with symptoms suggestive of gastroparesis［J］．Dig Dis Sci，1996，41（8）：1538-1545．DOI：10.1007/BF02087897.
［13］CAMILLERI M，CHEDID V，FORD A C，et al．Gastroparesis［J］．Nat Rev Dis Primers，2018，4（1）：41．DOI：10.1038/s41572-018-0038-z.
［14］TOUGAS G，EAKER E Y，ABELL T L，et al．Assessment of gastric emptying using a low fat meal：establishment of international control values［J］．Am J Gastroenterol，2000，95（6）：1456-1462.
［15］ORTHEY P，YU D，VAN NATTA M L，et al．Intragastric meal distribution during gastric emptying scintigraphy for assessment of fundic accommodation：correlation with symptoms of gastroparesis［J］．J Nucl Med，2018，59（4）：691-697．DOI：10.2967/jnumed.117.197053.
［16］KINDT S，TACK J.Impaired gastric accommodation and its role in dyspepsia［J］．Gut，2006，55（12）：1685-1691．DOI：10.1136/gut.2005.085365.
［17］VOSOUGHI K，ICHKHANIAN Y，JACQUES J，et al．Role of endoscopic functional luminal imaging probe in predicting the outcome of gastric peroral endoscopic pyloromyotomy（with video）［J］．Gastrointest Endosc，2020，91（6）：1289-1299．DOI：10.1016/j.gie.2020.01.044.
［18］WARD M P，GUPTA A，WO J M，et al．An emerging method to noninvasively measure and identify vagal response markers to enable bioelectronic control of gastroparesis symptoms with gastric electrical stimulation［J］．J Neurosci Methods，2020，336：108631．DOI：10.1016/j.jneumeth.2020.108631.
［19］STANGHELLINI V，CHAN F K L，HASLER W L，et al．Gastroduodenal disorders［J］．Gastroenterology，2016，150（6）：1380-1392．DOI：10.1053/j.gastro.2016.02.011.
［20］LACY B E.Functional dyspepsia and gastroparesis：one disease or two？［J］．Am J Gastroenterol，2012，107（11）：1615-1620．DOI：10.1038/ajg.2012.104.
［21］CHIAL H J，CAMILLERI M，WILLIAMS D E，et al．Rumination syndrome in children and adolescents：diagnosis，treatment，and prognosis［J］．Pediatrics，2003，111（1）：158-162．DOI：10.1542/peds.111.1.158.
［22］ALLEN J H，DE MOORE G M，HEDDLE R，et al．Cannabinoid hyperemesis：cyclical hyperemesis in association with chronic cannabis abuse［J］．Gut，2004，53（11）：1566-1570．DOI：10.1136/gut.2003.036350.
［23］SAGAR R C，SOOD R，GRACIE D J，et al．Cyclic vomiting syndrome is a prevalent and under-recognized condition in the gastroenterology outpatient clinic［J］．Neurogastroenterol Motil，2018，30（1）：e13174．DOI：10.1111/nmo.13174.
［24］JANSSEN P，HARRIS M S，JONES M，et al．The relation between symptom improvement and gastric emptying in the treatment of diabetic and idiopathic gastroparesis［J］．Am J Gastroenterol，2013，108（9）：1382-1391．DOI：10.1038/ajg.2013.118.
［25］SHEN S，XU J，LAMM V，et al．Diabetic gastroparesis and nondiabetic gastroparesis［J］．Gastrointest Endosc Clin N Am，2019，29（1）：15-25．DOI：10.1016/j.giec.2018.08.002.
［26］HOMKO C J，DUFFY F，FRIEDENBERG F K，et al．Effect of dietary fat and food consistency on gastroparesis symptoms in patients with gastroparesis［J］．Neurogastroenterol Motil，2015，27（4）：501-508．DOI：10.1111/nmo.12519.
［27］VANORMELINGEN C，TACK J，ANDREWS C N.Diabetic gastroparesis［J］．Br Med Bull，2013，105：213-230．DOI：10.1093/bmb/ldt003.
［28］TACK J.Prokinetics and fundic relaxants in upper functional GI disorders［J］．Curr Opin Pharmacol，2008，8（6）：690-696．DOI：10.1016/j.coph.2008.09.009.
［29］UKLEJA A，TANDON K，SHAH K，et al．Endoscopic botox injections in therapy of refractory gastroparesis［J］．World J Gastrointest Endosc，2015，7（8）：790-798．DOI：10.4253/wjge.v7.i8.790.
［30］GROVER M，FARRUGIA G，STANGHELLINI V.Gastroparesis：a turning point in understanding and treatment［J］．Gut，2019，68（12）：2238-2250．DOI：10.1136/gutjnl-2019-318712.
［31］PARKMAN H P，CAMILLERI M，FARRUGIA G，et al．Gastroparesis and functional dyspepsia：excerpts from the AGA/ANMS meeting［J］．Neurogastroenterol Motil，2010，22（2）：113-133．DOI：10.1111/j.1365-2982.2009.01434.x.
［32］PARKMAN H P.Idiopathic gastroparesis［J］．Gastroenterol Clin North Am，2015，44（1）：59-68．DOI：10.1016/j.gtc.2014.11.015.
［33］LIU N，ABELL T.Gastroparesis updates on pathogenesis and management［J］．Gut Liver，2017，11（5）：579-589．DOI：10.5009/gnl16336.
［34］SOOTA K，KEDAR A，NIKITINA Y，et al．Immunomodulation for treatment of drug and device refractory gastroparesis［J］．Results Immunol，2016，6：11-14．DOI：10.1016/j.rinim.2016.02.001.
［35］TACK J.The difficult patient with gastroparesis［J］．Best Pract Res Clin Gastroenterol，2007，21（3）：379-391．DOI：10.1016/j.bpg.2007.01.002.
［36］BHAYANI N H，SHARATA A M，DUNST C M，et al．End of the road for a dysfunctional end organ：laparoscopic gastrectomy for refractory gastroparesis［J］．J Gastrointest Surg，2015，19（3）：411-417．DOI：10.1007/s11605-014-2609-y.
［37］MILLER L S，SZYCH G A，KANTOR S B，et al．Treatment of idiopathic gastroparesis with injection of botulinum toxin into the pyloric sphincter muscle［J］．Am J Gastroenterol，2002，97（7）：1653-1660．DOI：10.1111/j.1572-0241.2002.05823.x.
［38］JAMES A N，RYAN J P，PARKMAN H P.Inhibitory effects of botulinum toxin on pyloric and antral smooth muscle［J］．Am J Physiol Gastrointest Liver Physiol，2003，285（2）：G291-297．DOI：10.1152/ajpgi.00296.2002.
［39］COLESKI R，ANDERSON M A，HASLER W L.Factors associated with symptom response to pyloric injection of botulinum toxin in a large series of gastroparesis patients［J］．Dig Dis Sci，2009，54（12）：2634-2642．DOI：10.1007/s10620-008-0660-9.
［40］BROMER M Q，FRIEDENBERG F，MILLER L S，et al．Endoscopic pyloric injection of botulinum toxin A for the treatment of refractory gastroparesis［J］．Gastrointest Endosc，2005，61（7）：833-869．DOI：10.1016/s0016-5107（05）00328-7.
［41］THOMAS A，DE SOUZA RIBEIRO B，MALESPIN M，et al．Botulinum toxin as a treatment for refractory gastroparesis：a literature review［J］．Curr Treat Options Gastroenterol，2018，16（4）：479-488．DOI：10.1007/s11938-018-0187-x.
［42］KHASHAB M A，BESHARATI S，NGAMRUENGPHONG S，et al．Refractory gastroparesis can be successfully managed with endoscopic transpyloric stent placement and fixation（with video）［J］．Gastrointest Endosc，2015，82（6）：1106-1109．DOI：10.1016/j.gie.2015.06.051.
［43］CAMILLERI M.Novel diet，drugs and gastric interventions for gastroparesis［J］．Clin Gastroenterol Hepatol，2016，14（8）：1072-1080．DOI：10.1016/j.cgh.2015.12.033.
［44］ABELL T，MCCALLUM R，HOCKING M，et al．Gastric electrical stimulation for medically refractory gastroparesis［J］．Gastroenterology，2003，125（2）：421-428．DOI：10.1016/s0016-5085（03）00878-3.
［45］MARANKI J L，LYTES V，MEILAHN J E，et al．Predictive factors for clinical improvement with Enterra gastric electric stimulation treatment for refractory gastroparesis［J］．Dig Dis Sci，2008，53（8）：2072-2078．DOI：10.1007/s10620-007-0124-7.
［46］LAL N，LIVEMORE S，DUNNE D，et al．Gastric electrical stimulation with the Enterra system：a systematic review［J］．Gastroenterol Res Pract，2015：762972．DOI：10.1155/2015/762972.
［47］SHLOMOVITZ E，PESCARUS R，CASSERA M A，et al．Early human experience with per-oral endoscopic pyloromyotomy（POP）［J］．Surg Endosc，2015，29（3）：543-551．DOI：10.1007/s00464-014-3720-6.
［48］CHAVES D M，DE MOURA E G H，MESTIERI L H M，et al．Endoscopic pyloromyotomy via a gastric submucosal tunnel dissection for the treatment of gastroparesis after surgical vagal lesion［J］．Gastrointest Endosc，2014，80（1）：164．DOI：10.1016/j.gie.2014.03.045.
［49］KHASHAB M A，NGAMRUENGPHONG S，CARR-LOCKE D，et al．Gastric per-oral endoscopic myotomy for refractory gastroparesis：results from the first multicenter study on endoscopic pyloromyotomy（with video）［J］．Gastrointest Endosc，2017，85（1）：123-128．DOI：10.1016/j.gie.2016.06.048.
［50］MEKAROONKAMOL P，DACHA S，PATEL V，et al．Outcomes of per oral endoscopic pyloromyotomy in the United States［J］．Gastrointest Endosc Clin N Am，2019，29（1）：151-160．DOI：10.1016/j.giec.2018.08.009.
［51］GONZALEZ J M，BENEZECH A，VITTON V，et al．G-POEM with antro-pyloromyotomy for the treatment of refractory gastroparesis：mid-term follow-up and factors predicting outcome［J］．Aliment Pharmacol Ther，2017，46（3）：364-370．DOI：10.1111/apt.14132.
［52］ABDELFATAH M M，LI B，KAPIL N，et al．Short-term outcomes of double pyloromyotomy versus single pyloromyotomy at peroral endoscopic pyloromyotomy in treatment of gastroparesis［J］．Gastrointest Endosc，2020，92（3）：603-609．DOI：10.1016/j.gie.2020.01.016.
［53］SHEN S，LUO H，VACHAPARAMBIL C，et al．Gastric peroral endoscopic pyloromyotomy versus gastric electrical stimulation in the treatment of refractory gastroparesis：a propensity score-matched analysis of long term outcomes［J］．Endoscopy，2020，52（5）：349-358．DOI：10.1055/a-1111-8566.
［54］GONZALEZ J M，LESTELLE V，BENEZECH A，et al．Gastric per-oral endoscopic myotomy with antropyloromyotomy in the treatment of refractory gastroparesis：clinical experience with follow-up and scintigraphic evaluation（with video）［J］．Gastrointest Endosc，2017，85（1）：132-139．DOI：10.1016/j.gie.2016.07.050.
［55］RODRIGUEZ J H，HASKINS I N，STRONG A T，et al．Per oral endoscopic pyloromyotomy for refractory gastroparesis：initial results from a single institution［J］．Surg Endosc，2017，31（12）：5381-5388．DOI：10.1007/s00464-017-5619-5.
［56］TU L，GHARIBANI P，YANG Y，et al．A novel approach in spinal cord stimulation for enhancing gastric motility：a preliminary study on canines［J］．J Neurogastroenterol Motil，2020，26（1）：147-159．DOI：10.5056/jnm19101.
［57］PASRICHA P J，YATES K P，NGUYEN L，et al．Outcomes and factors associated with reduced symptoms in patients with gastroparesis［J］．Gastroenterology，2015，149（7）：1762-1774.e4．DOI：10.1053/j.gastro.2015.08.008.
［58］PARKMAN H P，YATES K，HASLER W L，et al．Clinical features of idiopathic gastroparesis vary with sex，body mass，symptom onset，delay in gastric emptying，and gastroparesis severity［J］．Gastroenterology，2011，140（1）：101-115．DOI：10.1053/j.gastro.2010.10.015.

[1]	ZHANG Peng, LIU Lidi, ZHANG Ying, YANG Ziyu, LIU Changming, TANG Yijun, LIAO Xiaoyang, JIA Yu. Interpretation and Clinical Implications of the 2024 Italian Guidelines for the Management of Adult Individuals with Overweight and Obesity and Metabolic Comorbidities That are Resistant to Behavioral Treatment [J]. Chinese General Practice, 2025, 28(30): 3747-3752.
[2]	LI Hao, LI Peijin, LIU Tingting, CUI Yiyuan, LI Sicong, LIU Lixing, FENG Li, Working Group on Integrated Traditional Chinese and Western Medicine Diagnosis and Treatment Guidelines for Cancer Pain. Guidelines on the Diagnosis and Treatment of Cancer Pain by Integrated Traditional Chinese and Western Medicine [J]. Chinese General Practice, 2025, 28(30): 3729-3740.
[3]	ZHANG Tianyu, YU Haibo, CHEN Fei, LI Xin, ZHANG Jiajia, ZHAN Xiaokai, SHEN Man, TANG Ran, FAN Sibin, ZHAO Fengyi, HUANG Zhongxia. Meta-analysis of the Efficacy and Safety of Systemic Treatment for POEMS Syndrome [J]. Chinese General Practice, 2025, 28(27): 3447-3455.
[4]	ZHI Congcong, LI Xue, CHENG Yicheng, WANG Xiaolong, ZHENG Lihua. Guidelines for Integrated Traditional Chinese and Western Medicine Diagnosis and Treatment of Hemorrhoids (2025 Edition) [J]. Chinese General Practice, 2025, 28(26): 3217-3228.
[5]	WANG Yajing, DUAN Xiaoyang, HOU Ran, HUANG Yajie, SHI Jian. Advances in Targeted Combination Therapy for Patients with Brain Metastases from EGFR-mutated Non-small Cell Lung Cancer [J]. Chinese General Practice, 2025, 28(26): 3328-3337.
[6]	HUANG Yulin, WANG Haoyun, LI Yanmei, XIAO Xueying. Symptom Clusters in Gastric Cancer Patients Receiving Chemotherapy: a Scoping Review [J]. Chinese General Practice, 2025, 28(26): 3338-3344.
[7]	PAN Qi, REN Jingjing, MA Fanghui, HU Mengjie. Survey of General Practitioners' Cognition and Needs for AI Assisted Diagnosis and Treatment Systems [J]. Chinese General Practice, 2025, 28(25): 3127-3136.
[8]	RUAN Wanbai, LI Junfeng, YIN Yanmei, PENG Lei, ZHU Kexiang. Research Progress of Targeted Therapy and Immunotherapy for Pancreatic Cancer [J]. Chinese General Practice, 2025, 28(23): 2950-2960.
[9]	YANG Handan, QIAO Wen, HE Shu, CHEN Yi, TONG Yunmei. The Impact of Acceptance and Commitment Therapy Combined with Sertraline on Depressive Mood, Suicidal Ideation, and Sleep Quality of Adolescents with Depression [J]. Chinese General Practice, 2025, 28(22): 2813-2818.
[10]	Chinese Geriatrics Society, General Practice Branch of Zhejiang Medical Association, the Expert Collaboration Group on Medically Unspecified Disease in General Practice. Expert Consensus on the Diagnosis, Treatment, and Management of Emaciation (2025) [J]. Chinese General Practice, 2025, 28(21): 2577-2594.
[11]	WANG Ying, YAN Yijun, LIU Lei, HU Yumin, ZHANG Yang, LIU Kai, JIANG Boren. Effects of Resistance Exercise Combined with Nutritional Intervention on Blood Glucose Stability in Elderly Patients with Type 2 Diabetes Mellitus with Sarcopenia [J]. Chinese General Practice, 2025, 28(21): 2604-2610.
[12]	YANG Jiang, LI Jiansheng, CHEN Yaolong, LIU Huiguo, WANG Jianxin, YU Jiajie, LI Huiru, XIAO Qionghua, XIE Yang, LI Suyun, WANG Minghang. Guideline on Treating Adult Community-acquired Pneumonia with Chinese Patent Medicines (2025 Edition) [J]. Chinese General Practice, 2025, 28(20): 2464-2480.
[13]	BIAN Ying, YIN Gang, ZHANG Zixun, TAO Hongbing. The Mechanism of Information Construction Enabling High-quality Development of Compact County-level Medical Consortium [J]. Chinese General Practice, 2025, 28(19): 2426-2432.
[14]	LIU Hongya, YU Dehua. Construction and Practice of Clinical Diagnosis and Treatment Technology Combining General Practice and Specialist in Shanghai Community [J]. Chinese General Practice, 2025, 28(19): 2390-2397.
[15]	LUO Yunzhao, JIANG Hongchuan, XU Feng. Predicting Response to Neoadjuvant Therapy in Breast Cancer Using Deep Learning on Primary Core Needle Biopsy Slides [J]. Chinese General Practice, 2025, 28(19): 2407-2413.